09/29/2025 05:00
BECO Capital Raises $370 Million to Back Founders from Pre-Seed to IPO in the Gulf

BECO Capital announces the close of $370 million across two new funds, expanding BECO’s ability to back founders from Pre-Seed to IPO, with a continued focus on the UAE and Saudi Arabia. The raise includes $120 million for BECO Fund IV, the firm’s fourth early-stage fund, and a $250 million Growth Fund. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250928385582/en/BECO Capital’s General Partnership team from left to right: Yousef H...

09/29/2025 05:00
Solaris Selects ACI Connetic to Future-Proof Payments Infrastructure

ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, today announced that Solaris SE, Europe’s leading embedded finance platform, has selected ACI Connetic to consolidate all SEPA instant payments onto ACI Connetic, ACI’s leading-edge technology, cloud-native payments platform. ACI Connetic is the industry’s only unified solution that seamlessly integrates account-to-account (A2A) payments, card processing, and AI-powered fraud prevention within a single, modular ...

09/29/2025 05:14
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

Genmab A/S (Nasdaq: GMAB) and Merus N.V. (Nasdaq: MRUS) announced today that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company with its late-stage breakthrough therapy asset petosemtamab, which is in Phase 3 development, for USD 97.00 per share in an all-cash transaction representing a transaction value of approximately USD 8.0 billion. The transaction has been unanimously approved by the Bo...

09/29/2025 05:00
Virometix Announces Completion of Enrollment in Phase I Trial of V-212 — a Fully Synthetic, Serotype-Independent Vaccine Candidate Against Streptococcus Pneumoniae

Virometix AG, a Swiss clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced that it has successfully completed enrollment in the Phase I clinical trial of V-212, a peptide-based, serotype-independent vaccine candidate targeting Streptococcus pneumoniae infections. “Completing enrollment in this Phase I trial marks a significant milestone for V-212,” said Anna Sumeray, CEO of Virometix. “This fully synthetic, serotype-independent vaccine candidate is designe...

AFP Photographers Honoured at the 2024 POY Awards

Several AFP photographers have been honoured at the 82nd edition of the 2024 Pictures of the Year International (POY) awards, the world's oldest photojournalism competition, earning awards and special mentions across various categories.

Several AFP photographers have been honoured at the 82nd edition of the 2024 Pictures of the Year International (POY) awards, the world's oldest photojournalism competition, earning awards and special mentions across various categories.
10/27/2025 09:07
Comply Acquires Trailight to Accelerate Global Expansion and Create the Industry’s First Fully Integrated Firm and Employee Compliance Platform

Comply, the leading provider of regulatory and compliance technology solutions for financial firms, today announced it has acquired Trailight, the U.K.’s leading provider of purpose-built solutions for managing conduct risk, competence frameworks, and global accountability regimes. With the addition of Trailight, Comply becomes the first and only unified compliance platform to bring together firm compliance, employee compliance, individual accountability regime and archiving solutions across ...

09/29/2025 06:00
Corpay and Mastercard Move Extend Near Real-Time Payments to New Markets

Corpay and Mastercard announce today an expansion of their long-standing collaboration to enable corporates, small businesses and financial institutions to make near real-time payments to 22 new markets across Asia, Europe, the Middle East, Africa and Latin America. This milestone, revealed in Frankfurt at the annual Sibos conference builds on over a decade of collaboration between the two companies and leverages Mastercard Move’s money movement capabilities and its extensive network to deliver...

Correspondent - Berlin

Correspondent - Berlin

Starting date: September 1, 2025
Deadline for applications: July 25, 2025
Location: Berlin, Germany - Europe region
 

THE JOB


AFP is seeking a dynamic and motivated native-level English-speaking correspondent to join its reporting team in Berlin, Germany.

10/21/2025 06:30
Omdia: India Smartphone Market Grew 3% as Brands Gear Up for Festive Season

India’s smartphone market grew 3% year-on-year (YoY) in Q3 2025, reaching 48.4 million units shipped according to the latest research from Omdia. Vendors filled the channels with new stocks in expectation of a high-demand festive period. The modest growth was driven by a wave of new launches in July and August, retail incentivization and an earlier festive season that pulled forward inventory flows. This press release features multimedia. View the full release here: https://www.businesswire.co...